What are the injectable medications for treating rheumatoid arthritis?
May 16, 2023
Source: Cainiu Health
Dr. Liu Aihua
Introduction
Injectable treatments for rheumatoid arthritis include biologic agents, glucocorticoids, and synthetic antirheumatic drugs. Biologic agents primarily target the immune system, glucocorticoid injections can rapidly relieve symptoms, and synthetic antirheumatic drugs inhibit inflammatory mediators in the immune system. Sodium hyaluronate injections are also available for joint fluid replacement. Treatment should be conducted under a physician's guidance.
Generally, injectable agents used to treat rheumatoid arthritis include biologic agents, glucocorticoids, and synthetic anti-rheumatic drugs. A detailed analysis is as follows:
1. Biologic Agents
Biologic agents are a class of medications derived from biotechnology, manufactured primarily through genetic engineering and cell culture techniques. These agents specifically target certain components of the immune system, such as cytokines and cell surface receptors, to modulate or suppress immune responses, thereby treating autoimmune diseases like rheumatoid arthritis. Common biologic agents include exenatide injection and moxifloxacin injection.
2. Glucocorticoids
Glucocorticoid injections can rapidly alleviate symptoms and quickly reduce the degree of inflammatory response, enabling patients to recover swiftly. They also decrease metabolism in the liver, resulting in higher bioavailability and relatively fewer side effects. Common glucocorticoids include prednisolone injection and dexamethasone injection.
3. Synthetic Anti-Rheumatic Drugs
Synthetic anti-rheumatic drugs are chemically synthesized medications that inhibit inflammatory mediators in the immune system, thus relieving symptoms of rheumatoid arthritis. Commonly used injectable forms include methotrexate injection and azathioprine injection.
In addition to the above, other injectable agents for treating rheumatoid arthritis include hydrocortisone acetate injection, technetium-99m methylene diphosphonate injection, and sodium hyaluronate injection. The selection of injectable therapy should be based on the patient's specific condition and disease severity, and must be conducted under the guidance of a physician.
